ACE Launches Enhanced Clinical Trials Liability Cover for UK Companies

ACE Group has launched an enhanced clinical trials liability proposition for UK companies, which provides life science companies with specialist insurance for clinical trials programs conducted anywhere in the world.

With the need for clinical trials to be initiated and completed within short timescales, the high number of changes in regulation and requirements within the UK and overseas as well as the increasing number of trials ran in emerging territories, it is imperative that companies have the right insurance cover in place.

The ACE clinical trials product has been developed in direct response to these needs, offering timely and compliant cover as well as flexible solutions equally suitable for single trials and for large multinational multiple trial programs, ACE said in a statement.

The proposition is designed with pharmaceutical manufacturers, biotechnology organizations, medical device and equipment manufacturers, generics companies and research organizations in mind. It is available for all phases, all types of patients, all types of disease, all types of pharmaceutical and biotech products and medical devices.

Details of the enhanced cover include:

“Clinical trials are a key stage in the development of medicinal products and providing compliant cover and quick turnarounds ultimately benefits both patients and companies,” said Mark Roberts, casualty manager, UK & Ireland at ACE.

Claire Wilkinson is ACE’s in-house clinical trials expert, based in the UK.

Source: ACE Group